Skip to Main Content

Paper Details

Stratification of responders towards eculizumab using a structural epitope mapping strategy.
Sci Rep
14
2016
C5, OmCI, Ornithodorus moubata, Ornithodorus moubata complement inhibitor, PNH, aHUS, atypical haemolytic uremic syndrome, binding site, complement component 5, eculizumab, epitope, human, human C5, paroxysmal nocturnal hemoglobinuria, patients
Author NameAffiliation
Anna-Luisa VolkKTH - Royal Institute of Technology
Anna-Luisa VolkKTH Center for Applied Proteomics, KTH - Royal Institute of Technology
Mathias Uhl??nKTH - Royal Institute of Technology
Mathias Uhl??nNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Mathias Uhl??nKTH - Royal Institute of Technology
Mathias Uhl??nKTH Center for Applied Proteomics, KTH - Royal Institute of Technology
Mathias Uhl??nKTH - Royal Institute of Technology
Mathias Uhl??nKTH Center for Applied Proteomics, KTH - Royal Institute of Technology
Mathias Uhl??nKTH - Royal Institute of Technology
Mathias Uhl??nNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Johan RockbergKTH - Royal Institute of Technology
  • 1 - 11

Datasets

Release 1.2